VTA yields 122.59% · MRK yields 2.76%● Live data
📍 VTA pulled ahead of the other in Year 1
Combined, VTA + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VTA + MRK for your $10,000?
Invesco Dynamic Credit Opportunities Fund is a diversified closed-end management investment company. The Fund's investment objective is to seek a high level of current income, with a secondary objective of capital appreciation. The Fund invests primarily in a portfolio of interests in floating or variable senior loans to corporations, partnerships and other entities, which operate in a range of industries and geographic regions. The Fund invests in various sectors, which include business equipment and services; electronics and electrical; retailers (except food and drug); telecommunications; utilities; food products; healthcare; leisure goods, activities and movies; lodging and casinos; oil and gas; containers and glass products; structured products; cable and satellite television, and financial intermediaries. It may invest in senior loans to borrowers that are organized or located in countries other than the United States. The Fund's investment advisor is Invesco Advisers, Inc.
Full VTA Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.